# Bortezomib

NDC: 72603-270
Generic name: Bortezomib
Labeler / Manufacturer: NorthStar RxLLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: INTRAVENOUS, SUBCUTANEOUS
Marketing started: 20241101

FDA application: ANDA202963

## Active ingredients

- BORTEZOMIB: 3.5 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"72603-270"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=72603-270
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3f02670b-5683-780c-9d38-5d8f0ef43a14